Peter A. Meyers Insider Trading $EGRX EAGLE PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter A. Meyers.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A. Meyers. Peter A. Meyers is CFO & Treasurer in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and Chief Financial Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX).
Peter A. Meyers in EAGLE PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A. Meyers: Chief Financial Officer
Holdings: 45,900 shares
Current Value: $3,187,296
Latest Transaction: Jan 07 2020
$EGRX Market Capitalization: $1.09B
$EGRX Previous Close: $69.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter A. Meyers in EAGLE PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 59.80 | 48,000 | 2,870,160 | 48,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Payment of Exercise | F | 57.38 | 632 | 36,264 | 45,268 | 45.9 K to 45.3 K (-1.38 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 19,500 | 0 | 45,900 | 26.4 K to 45.9 K (+73.86 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 42.40 | 43,200 | 1,831,680 | 43,200 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 19,300 | 0 | 26,400 | 7.1 K to 26.4 K (+271.83 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Payment of Exercise | F | 41.33 | 600 | 24,798 | 7,100 | 7.7 K to 7.1 K (-7.79 %) |
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 0.00 | 21,000 | 0 | 21,000 | |
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 59.14 | 37,000 | 2,188,180 | 37,000 | |
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 7,000 | 0 | 7,700 | 700 to 7.7 K (+1,000.00 %) |
| Aug 16 2017 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Buy | P | 55.45 | 350 | 19,406 | 700 | 350 to 700 (+100.00 %) |
| Jun 12 2017 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Buy | P | 71.49 | 350 | 25,021 | 350 | 0 to 350 |
| May 15 2017 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 82.30 | 50,000 | 4,115,000 | 50,000 |
Page: 1